Skip to main content
. 2018 Aug 10;16(4):5473–5481. doi: 10.3892/ol.2018.9291

Table I.

IC50 of MK-1775 against ALL cell lines.

Cell line Cell type p53 IC50, nM
Nalm-6 B-ALL WT 45.9±3.9a
Sup-T1 T-ALL MUT 347.4±95.0a
Jurkat T-ALL MUT 137.4±33.9a
Molt-4 T-ALL MUT 67.6±31.8a
HS-5 BMSC WT 1,472.0±304.8

ALL, acute lymphoblastic leukemia; B-ALL, B-cell acute lymphoblastic leukemia; T-ALL, T-cell acute lymphoblastic leukemia; WT, wild type; MUT, mutation. MUT, mutated; WT, wild type; p%£, tumor protein 53; IC50, half-maximal inhibitory concentration.

a

P<0.05 compared with HS-5 cell line.